| 104863-6 | Ketamine (Urine, qualitative, lc/ms/ms) | DRUG/TOX |
| 104864-4 | Beta lactamase.extended spectrum (qualitative) | ABXBACT |
| 104865-1 | Bacteria (Urine, qualitative, computer assisted method) | MICRO |
| 104866-9 | Microscopic observation in Cervix (cyto stain.thin prep.computer assisted) | CYTO |
| 104867-7 | PET+CT Heart metabolic | RAD |
| 104868-5 | PET+CT Heart perfusion W multiple studies at rest+W stress | RAD |
| 104869-3 | CT Brain during surgery | RAD |
| 10487-7 | HMB-45 Ag (Tissue, qualitative, immune stain) | PATH |
| 104870-1 | CT Cervical spine during surgery | RAD |
| 104871-9 | Histoplasma capsulatum+Blastomyces dermatitidis Ag (Urine, qualitative, immunoassay) | MICRO |
| 104872-7 | Histoplasma capsulatum+Blastomyces dermatitidis Ag (Urine, immunoassay) | MICRO |
| 104873-5 | Glucose dumping syndrome panel - Serum, Plasma or Blood | PANEL.HEM/BC |
| 104874-3 | Hematocrit (calculation --baseline) | HEM/BC |
| 104875-0 | Hematocrit --30 minutes post dose glucose (Blood) | CHAL |
| 104876-8 | Hematocrit --1 hour post dose glucose (Blood) | CHAL |
| 104877-6 | Hematocrit --1.5 hours post dose glucose (Blood) | CHAL |
| 104878-4 | Hematocrit --2 hours post dose glucose (Blood) | CHAL |
| 104879-2 | Hematocrit --2.5 hours post dose glucose (Blood) | CHAL |
| 10488-5 | IgA Ag (Tissue, qualitative, immune stain) | PATH |
| 104880-0 | Hematocrit --3 hours post dose glucose (Blood) | CHAL |
| 104881-8 | Equine acute pain scale Animal (qualitative) | CLIN.VET |
| 104882-6 | Feline acute pain scale Animal (qualitative) | CLIN.VET |
| 104883-4 | Phosphorus.reabsorbed (qualitative, renal tubules/phosphorus.total filtered in urine and serum or plasma qualitative) | CHEM |
| 104884-2 | Tubular reabsorption of phosphorus panel - Urine and Serum or Plasma | PANEL.CHEM |
| 104886-7 | Remission status Narrative | ADMIN |
| 104887-5 | Problem occurrence Narrative | ADMIN |
| 104888-3 | Duration of reaction | ADMIN |
| 104889-1 | Admission reason Narrative | ADMIN |
| 10489-3 | IgA.heavy chain Ag (Tissue, qualitative, immune stain) | PATH |
| 104890-9 | Nationality Person Narrative | ADMIN |
| 104891-7 | Communication aid Person Narrative | ADMIN |
| 104892-5 | Number of potentially affected (condition family member) | ADMIN |
| 104893-3 | Information updated date and time | ADMIN |
| 104894-1 | Genetic predisposition indicator Person Narrative | ADMIN |
| 104895-8 | Problem related issues Narrative | ADMIN |
| 104896-6 | Resolution phase Narrative | ADMIN |
| 104897-4 | Longitude | DOC.ADMIN |
| 104898-2 | Event outcome Narrative | ADMIN |
| 104899-0 | Number of affected family members | ADMIN |
| 1049-6 | H NOS Ag on Red Blood Cells from Donor (qualitative) | BLDBK |
| 10490-1 | IgE Ag (Tissue, qualitative, immune stain) | PATH |
| 104900-6 | Role Narrative | DOC.ADMIN |
| 104901-4 | Condition biomarker description Narrative | ADMIN |
| 104902-2 | Electronic communication information | ADMIN |
| 104903-0 | Indication Facility | ADMIN |
| 104904-8 | Problem level of control Narrative | ADMIN |
| 104905-5 | Duration of exposure | ADMIN |
| 104906-3 | Procedure end date and time | ADMIN |
| 104907-1 | Indication Narrative | ADMIN |
| 104908-9 | Relationship family line Person Narrative | ADMIN |